Arcadia Biosciences Obtains U.S. FDA GRAS Status for SONOVA® GLA Safflower Oil
January 10 2017 - 8:00AM
Business Wire
-- GRAS Notification Expands Application
Options for Nutritional Oil Rich in Gamma-linolenic acid (GLA) for
Uses in Nutritional Beverages and Medical Foods --
Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural
technology company, announced today that the U.S. Food and Drug
Administration (FDA) has accepted Arcadia’s conclusion that its
SONOVA® GLA safflower oil is “generally recognized as safe” (GRAS)
for use in nutritional beverages and medical foods.
Arcadia produces GLA safflower nutritional oils with high
concentrations of gamma-linolenic acid (GLA). These oils are
marketed by Arcadia under the SONOVA® brand and are currently used
in nutritional supplement products. GLA is a nutritionally
important omega-6 fatty acid that helps support the body’s
anti-inflammatory response and is especially useful for managing
weight, improving skin health and maintaining hormonal balance for
women. When used in combination with the omega-3 fatty acids
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), GLA has
been shown to support heart and eye health.
“This FDA GRAS notification expands the application options for
Arcadia’s SONOVA® GLA safflower oil, opening adjacent markets for
our customers in nutritional beverages and medical foods,” said Raj
Ketkar, president and CEO of Arcadia Biosciences. “By providing our
customers with oil containing two to three times the concentration
of other sources of GLA, we expect our proprietary SONOVA® GLA
safflower oil to provide important health benefits at a superior
cost position.”
Arcadia followed FDA-proposed procedures to establish its
SONOVA® GLA safflower oil as GRAS under the intended conditions of
use. This process included convening an expert panel to review the
necessary product safety data and then submitting a notification to
the FDA.
SONOVA® GLA safflower oil is produced in the United States under
strict identity preservation protocols and is currently available
in several forms, including bulk oil, soft gels and powder. SONOVA®
400 GLA Safflower Oil contains 40 percent GLA, four times the
concentration of evening primrose oil and twice the concentration
of borage oil. SONOVA® ULTRA GLA Safflower Oil contains 55 percent
GLA.
For samples and more information, visit www.SonovaGLA.com.
About Arcadia Biosciences, Inc.
Based in Davis, Calif., Arcadia Biosciences (Nasdaq: RKDA)
develops agricultural products that create added value for farmers
while benefitting the environment and enhancing human health.
Arcadia’s agronomic performance traits, including Nitrogen Use
Efficiency, Water Use Efficiency, Salinity Tolerance, Heat
Tolerance and Herbicide Tolerance, are all aimed at making
agricultural production more economically efficient and
environmentally sound. Arcadia’s nutrition traits and products are
aimed at creating healthier ingredients and whole foods with lower
production costs.
Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995, including statements relating to the company’s traits and the
regulatory process for such traits. Forward-looking statements are
subject to risks and uncertainties that could cause actual results
to differ materially, and reported results should not be considered
as an indication of future performance. These risks and
uncertainties include, but are not limited to: the company’s and
its partners’ and affiliates’ ability to identify and isolate
desired traits; the company’s and its partners’ ability to develop
commercial products incorporating its traits, and complete the
regulatory review process for such products; the company’s
compliance with laws and regulations that impact the company’s
business, and changes to such laws and regulations; the company’s
future capital requirements and ability to satisfy its capital
needs; and the other risks set forth in the company’s filings with
the Securities and Exchange Commission from time to time, including
the risks set forth in the company’s Quarterly Report on Form 10-Q
for the quarter ended September 30, 2016 and other filings. These
forward-looking statements speak only as of the date hereof, and
Arcadia Biosciences, Inc. disclaims any obligation to update these
forward-looking statements.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170110005418/en/
Arcadia Biosciences, Inc.Jeff
Bergaujeff.bergau@arcadiabio.com+1-312-217-0419
Arcadia Biosciences (NASDAQ:RKDA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Arcadia Biosciences (NASDAQ:RKDA)
Historical Stock Chart
From Apr 2023 to Apr 2024